Patents by Inventor Stephen E. Butts

Stephen E. Butts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230416195
    Abstract: The present invention relates to a method of treating cataplexy in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Application
    Filed: June 19, 2023
    Publication date: December 28, 2023
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts
  • Patent number: 11713292
    Abstract: The present invention relates to a method of treating cataplexy in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Grant
    Filed: July 23, 2021
    Date of Patent: August 1, 2023
    Assignees: Axsome Malta Ltd, SK Biopharmaceuticals Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts
  • Publication number: 20230172896
    Abstract: The present invention relates to a method for treating or preventing obesity in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds. The invention further relates to methods for reducing body weight and/or reducing food intake in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Application
    Filed: November 14, 2022
    Publication date: June 8, 2023
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts
  • Publication number: 20230136792
    Abstract: The present invention relates to methods of treating, delaying the onset of, slowing the progression of, or reducing the severity of age-related diseases by administering a compound of Formula 1 to a subject in need thereof. The invention further relates to methods of treating, delaying the onset of, slowing the progression of, or reducing the severity of premature aging disorders by administering a compound of Formula 1 to a subject in need thereof.
    Type: Application
    Filed: April 1, 2021
    Publication date: May 4, 2023
    Inventors: Michael Friedrich Ackermann, Kelly J. Abernathy, Gregory Cooksey Rigdon, Stephen E. Butts
  • Patent number: 11497725
    Abstract: The present invention relates to a method for treating or preventing obesity in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds. The invention further relates to methods for reducing body weight and/or reducing food intake in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Grant
    Filed: September 22, 2020
    Date of Patent: November 15, 2022
    Assignees: Axsome Malta Ltd., SK Biopharmaceuticals Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts
  • Publication number: 20220017457
    Abstract: The present invention relates to a method of treating cataplexy in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Application
    Filed: July 23, 2021
    Publication date: January 20, 2022
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts
  • Patent number: 11072579
    Abstract: The present invention relates to a method of treating cataplexy in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: July 27, 2021
    Assignees: Jazz Pharmaceuticals Ireland Limited, SK Biopharmaceuticals Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts
  • Publication number: 20210077450
    Abstract: The present invention relates to a method for treating or preventing obesity in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds. The invention further relates to methods for reducing body weight and/or reducing food intake in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Application
    Filed: September 22, 2020
    Publication date: March 18, 2021
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts
  • Publication number: 20200061017
    Abstract: The present invention relates to the use of compounds of the invention for treatment and/or prevention of fatigue, including fatigue associated with diseases or treatments.
    Type: Application
    Filed: October 31, 2019
    Publication date: February 27, 2020
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts, Susan Marie Melnick, Duncan Taylor
  • Patent number: 10507192
    Abstract: The present invention relates to the use of compounds of the invention for treatment and/or prevention of fatigue, including fatigue associated with diseases or treatments.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: December 17, 2019
    Assignee: SK Biopharmaceuticals Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts, Susan Marie Melnick, Duncan Taylor
  • Publication number: 20190218174
    Abstract: The present invention relates to a method of treating cataplexy in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Application
    Filed: March 20, 2019
    Publication date: July 18, 2019
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts
  • Patent number: 10259780
    Abstract: The present invention relates to a method of treating cataplexy in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Grant
    Filed: January 30, 2017
    Date of Patent: April 16, 2019
    Assignees: Jazz Pharmaceuticals International III Limited, SK Biopharmaceuticals Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts
  • Publication number: 20190099395
    Abstract: The present invention relates to a method for treating or preventing obesity in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds. The invention further relates to methods for reducing body weight and/or reducing food intake in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Application
    Filed: September 27, 2018
    Publication date: April 4, 2019
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts
  • Patent number: 10105341
    Abstract: The present invention relates to a method for treating or preventing obesity in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds. The invention further relates to methods for reducing body weight and/or reducing food intake in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Grant
    Filed: May 12, 2017
    Date of Patent: October 23, 2018
    Assignees: Jazz Pharmaceuticals International III Limited, SK Biopharmaceuticals Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts
  • Publication number: 20180263950
    Abstract: The present invention relates to the use of compounds of the invention for treatment and/or prevention of fatigue, including fatigue associated with diseases or treatments.
    Type: Application
    Filed: May 18, 2018
    Publication date: September 20, 2018
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts, Susan Marie Melnick, Duncan Taylor
  • Patent number: 9999609
    Abstract: The present invention relates to the use of compounds of the invention for treatment and/or prevention of fatigue, including fatigue associated with diseases or treatments.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: June 19, 2018
    Assignee: SK Biopharmaceuticals Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts, Susan Marie Melnick, Duncan Taylor
  • Publication number: 20170340596
    Abstract: The present invention relates to a method for treating or preventing obesity in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds. The invention further relates to methods for reducing body weight and/or reducing food intake in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Application
    Filed: May 12, 2017
    Publication date: November 30, 2017
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts
  • Publication number: 20170137375
    Abstract: The present invention relates to a method of treating cataplexy in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Application
    Filed: January 30, 2017
    Publication date: May 18, 2017
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts
  • Patent number: 9649291
    Abstract: The present invention relates to a method for treating or preventing obesity in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds. The invention further relates to methods for reducing body weight and/or reducing food intake in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Grant
    Filed: December 1, 2015
    Date of Patent: May 16, 2017
    Assignees: Jazz Pharmaceuticals International III Limited, SK Biopharmaceuticals Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts
  • Patent number: 9585863
    Abstract: The present invention relates to a method of treating cataplexy in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.
    Type: Grant
    Filed: May 9, 2016
    Date of Patent: March 7, 2017
    Assignees: Jazz Pharmaceuticals International III Limited, SK Biopharmaceuticals Co., Ltd.
    Inventors: Moise A. Khayrallah, Gary Bream, Stephen E. Butts